Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Table_5_Episodic Decrease in Temperature Increases mcy Gene Transcription and Cellular Microcystin in Continuous Cultures of Microcystis aeruginosa PCC 7806.XLSX by Robbie M. Martin (4686418)

Cdk5 inhibition by olomoucine prevents the fragmentation of the Golgi and decreases Tau secretion. by Nguyen-Vi Mohamed (323606)

Clustal W alignment of amino acid sequences of <i>Pf</i>HtrA2 with its homologs in organisms. by Shweta Singh (409313)

Ligand-Controlled Magnetic Interactions in Mn₄ Clusters by Erik Kampert (2330428)

“…Experimentally measured magnetic moments in high magnetic fields show that, upon electron density withdrawal, the main antiferromagnetic exchange constant <i>J</i>₁ decreases from −2.2 K for the [Mn₄(OAc)₄] cluster to −1.9 K for the [Mn₄(H₅C₆COO)₄] cluster and −0.6 K for the [Mn₄(F₃CCOO)₄] cluster, while <i>J</i>₂ decreases from −1.1 K to nearly 0 K and <i>J</i>₃ changes to a small ferromagnetic coupling. …”

Ligand-Controlled Magnetic Interactions in Mn₄ Clusters by Erik Kampert (2330428)

“…Experimentally measured magnetic moments in high magnetic fields show that, upon electron density withdrawal, the main antiferromagnetic exchange constant <i>J</i>₁ decreases from −2.2 K for the [Mn₄(OAc)₄] cluster to −1.9 K for the [Mn₄(H₅C₆COO)₄] cluster and −0.6 K for the [Mn₄(F₃CCOO)₄] cluster, while <i>J</i>₂ decreases from −1.1 K to nearly 0 K and <i>J</i>₃ changes to a small ferromagnetic coupling. …”

A disrupted Ets-binding site decreases NK-Pro transcription and HLA-C expression, resulting in higher lytic activity of NK cells. by Hongchuan Li (375905)

One-step and multi-step growth curves each mutant and SVA-WT. by Hai-Fan Zhao (15990862)

Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation. by Zhijun Zhang (315079)

Subjects:

ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)